RCM
TRIB

RNC Capital Management’s Trinity Biotech TRIB Stock Holding History

RNC Capital Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,367
Closed -$250K – 146
2015
Q3 		$250K Sell
4,367
-190
-4% -$15.3K 0.02% 108
2015
Q2 		$412K Sell
4,557
-48
-1% -$4.16K 0.04% 89
2015
Q1 		$443K Buy
4,605
+1,940
+73% +$179K 0.04% 89
2014
Q4 		$233K Buy
+2,665
New +$230K 0.02% 120
2014
Q3 		– Sell
-1,756
Closed -$202K – 132
2014
Q2 		$202K Buy
+1,756
New +$208K 0.02% 121

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

RNC Capital Management's TRIB Position: Q4 2015 in Review

RNC Capital Management sold out of Trinity Biotech (TRIB) in Q4 2015, closing a stake of 4,367 shares — an estimated $250K sold.

RNC Capital Management first reported a position in TRIB in Q2 2014 and held it in 5 quarters. The position peaked at $443K in Q1 2015. 82 funds tracked by Wall St. Rank hold TRIB as of Q4 2015.

  • RNC Capital Management reported no remaining Trinity Biotech position as of Q4 2015 after selling out during the quarter.
  • RNC Capital Management sold 4,367 Trinity Biotech shares in Q4 2015, an estimated $250K.
  • RNC Capital Management first reported a position in Trinity Biotech in Q2 2014 and held it in 5 quarters.
  • RNC Capital Management's Trinity Biotech position peaked at $443K in Q1 2015.
  • 82 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2015.

Based on RNC Capital Management's 13F filing for Q4 2015, filed 13 Jan 2016.